NGAL ELISA (Lipocalin)

$1,025.00
Catalog
54-036

The NGAL ELISA (Lipocalin) is for the determination of NGAL (neutrophil gelatinase-associated lipocalin) in human serum, plasma, tissue extracts or culture media. For research use only. Not for use in diagnostic procedures.

Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in North America Only
Range
10-1000 pg/mL
Sensitivity
4 pg/mL
Sizes
96 Wells
Sample Types
Cell Culture, Plasma, Serum, Tissue Culture, Urine
Inc Time Hour
3
Inc Time Minute
10
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
10
Detection
Colorimetric
NGAL is a biomarker of kidney tubular damage and a biological response to the damage process which is distinctly separated from loss of kidney function called Acute Kidney Injury (AKI)1. As damage often precedes loss of function renal expression of NGAL increases dramatically in a variety of causes and NGAL is released into both urine and plasma. Accordingly, renal disorders with presence of acute tubular damage are associated with raised urinary and plasma NGAL levels. Urinary NGAL serves as an early marker of acute kidney injury after cardiopulmonary bypass surgery2,3 and both urinary and plasma NGAL levels provide an early indication of acute renal injury in unselected patients in intensive care4. Raised urinary and plasma levels of NGAL have also been observed in patients with chronic kidney diseases5, and persistently raised urinary levels after renal transplantation are associated with poor graft function6.

NGAL ELISA (Lipocalin)

54-036

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Salem, NH, December 19, 2023 – Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the...
View Now
Targeted Solutions for Gastroenterology
Targeted Solutions for Gastroenterology
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.
View Now
 Optimizing IBD Management with Fecal Calprotectin: From Diagnosis to Monitoring
Live Webinar: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.